Lucio Morabito

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Spotlight on Melphalan Flufenamide: An Up-and-Coming Therapy for the Treatment of Myeloma.

Spotlight on Melphalan Flufenamide: An Up-and-Coming Therapy for the Treatment of Myeloma.

Journal: Drug design, development and therapy

Published: May 14, 2021

Clinical relevance of clonal hematopoiesis in persons aged ≥80 years.

Clinical relevance of clonal hematopoiesis in persons aged ≥80 years.

Journal: Blood

Published: February 16, 2021

Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes.

Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: February 04, 2021

TP53 dysfunction in chronic lymphocytic leukemia: clinical relevance in the era of B-cell receptors and BCL-2 inhibitors.

TP53 dysfunction in chronic lymphocytic leukemia: clinical relevance in the era of B-cell receptors and BCL-2 inhibitors.

Journal: Expert opinion on investigational drugs

Published: June 20, 2020

SARS-CoV-2 Interstitial Pneumonia Treated With Tocilizumab in a Patient Affected by Classical Hodgkin Lymphoma.

SARS-CoV-2 Interstitial Pneumonia Treated With Tocilizumab in a Patient Affected by Classical Hodgkin Lymphoma.

Journal: HemaSphere

Published: May 13, 2020

An in-depth evaluation of acalabrutinib for the treatment of mantle-cell lymphoma.

An in-depth evaluation of acalabrutinib for the treatment of mantle-cell lymphoma.

Journal: Expert opinion on pharmacotherapy

Published: November 19, 2019

Pretransplant active disease status and HLA class II mismatching are associated with increased incidence and severity of cytokine release syndrome after haploidentical transplantation with posttransplant cyclophosphamide.

Pretransplant active disease status and HLA class II mismatching are associated with increased incidence and severity of cytokine release syndrome after haploidentical transplantation with posttransplant cyclophosphamide.

Journal: Cancer medicine

Published: May 24, 2019

Lenalidomide for the treatment of mantle cell lymphoma.

Lenalidomide for the treatment of mantle cell lymphoma.

Journal: Expert opinion on pharmacotherapy

Published: January 05, 2019

Genomic Integration of HHV-6 Mimicking Viral Reactivation after Autologous Stem Cell Transplantation.

Genomic Integration of HHV-6 Mimicking Viral Reactivation after Autologous Stem Cell Transplantation.

Journal: Mediterranean journal of hematology and infectious diseases

Published: October 03, 2017

T Cell-Replete Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for Hodgkin Lymphoma Relapsed after Autologous Transplantation: Reduced Incidence of Relapse and of Chronic Graft-versus-Host Disease Compared with HLA-Identical Related Donors.

T Cell-Replete Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for Hodgkin Lymphoma Relapsed after Autologous Transplantation: Reduced Incidence of Relapse and of Chronic Graft-versus-Host Disease Compared with HLA-Identical Related Donors.

Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation

Published: September 27, 2017

A reduced dose of fluconazole as primary antifungal prophylaxis is not associated with increased risk of invasive fungal infections after allogeneic stem cell transplantation from a HLA identical sibling.

A reduced dose of fluconazole as primary antifungal prophylaxis is not associated with increased risk of invasive fungal infections after allogeneic stem cell transplantation from a HLA identical sibling.

Journal: Transplant infectious disease : an official journal of the Transplantation Society

Published: July 01, 2017

Tandem autologous-haploidentical transplantation is a feasible and effective program for refractory Hodgkin lymphoma.

Tandem autologous-haploidentical transplantation is a feasible and effective program for refractory Hodgkin lymphoma.

Journal: Bone marrow transplantation

Published: May 25, 2017

Showing 1-12 of 26

Last Updated: 09/26/2026